- Home
- CHCT vs AUTL Comparison
CHCT vs AUTL Comparison
Compare CHCT & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHCT | AUTL |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 493.1M | 431.2M |
| IPO Year | 2015 | 2025 |
Fundamental Metrics
Financial Performance| Metric | CHCT | AUTL |
|---|---|---|
| Price | $16.60 | $1.49 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $18.00 | $8.50 |
| AVG Volume (30 Days) | 357.3K | ★ 1.5M |
| Earning Date | 05-20-2026 | 01-01-0001 |
| Dividend Yield | ★ 11.83% | N/A |
| EPS Growth | ★ 134.78 | 28.33 |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $121,195,000.00 | $10,120,000.00 |
| Revenue This Year | $9.06 | $669.62 |
| Revenue Next Year | $8.61 | $79.78 |
| P/E Ratio | $201.88 | ★ N/A |
| Revenue Growth | 4.67 | ★ 496.00 |
| 52 Week Low | $13.23 | $1.11 |
| 52 Week High | $18.90 | $2.70 |
Technical Indicators
Market Signals| Indicator | CHCT | AUTL |
|---|---|---|
| Relative Strength Index (RSI) | 44.43 | 44.95 |
| Support Level | $16.29 | $1.45 |
| Resistance Level | $17.34 | $1.52 |
| Average True Range (ATR) | 0.43 | 0.11 |
| MACD | -0.09 | -0.02 |
| Stochastic Oscillator | 39.22 | 13.79 |
Price Performance
Historical ComparisonAbout CHCT Community Healthcare Trust Incorporated
Community Healthcare Trust Inc is an integrated healthcare real estate company in the United States. The company owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems, or other healthcare service providers in non-urban markets. The company derives the majority of its revenues from its real estate property and mortgage notes portfolio. The company's rental and mortgage interest income is recognized based on contractual arrangements with its tenants and borrowers.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.